Pharma
Nuclera closes $75 million USD financing
Series C round led by Elevage Medical Technologies. Funding will accelerate the commercialization of Nuclera’s eProtein Discovery platform, to optimize protein expression and purification workflows within research labs globally. ...
Benefits of a Nitrosamine Selective Detector
Nitrosamines, such as N-Nitrosodimethylamine (NDMA), are carcinogenic compounds that can form during the drug manufacturing process and storage under certain conditions. These contaminants pose significant health risks, and their presence in medications like Ranitidine has already led t...
Guardtech Group bag third win in two months with West Suffolk Innovation of the Year Award
Haverhill-based cleanroom construction specialists scoop Bury Free Press Awards win for Innovation with portable container business Cleancube Mobile Cleanrooms ...
AstraZeneca unveils The Hub, a new amenities centre, on Cambridge Biomedical Campus
AstraZeneca has today officially opened The Hub in Cambridge, a purposely designed amenities centre, where employees and the local community can collaborate, socialise and unwind. Located at the heart of the Cambridge Biomedical Campus (CBC), The Hub offers a wide range of facilities an...
DREAM: Develop, Research, Engineer, Assemble and Manufacture with a Guardtech Cleanrooms modular
The Guardtech Group’s more modest modular specialists are helping applications reach new levels with their affordable yet high-quality systems ...
Milner Seminar - Focus on immuno-oncology
Join us on 28th November for the next Milner Seminar. Talks will be followed by networking and refreshments. ...
More on Microfluidic Embedded Electronics Manufacturing
IPFL recently developed a sophisticated component that integrates embedded electronics within a microfluidic system using advanced micro 3D printing technology. Leveraging BMF’s 10µm and 2µm resolution systems, IPFL produced an intricate connector that seamlessly joins two bioreactors, ...
Guardtech Group gearing up for Nordics exhibition double at R3 and Tema Renrum
THE GUARDTECH GROUP are all set for an exciting double expo appearance in the Nordics this autumn at the R3 Nordic Annual Symposium & Exhibition in October and Tema Renrum a month later. ...
Nxera Pharma appoints experienced commercial R&D executive Makoto Sugita as Chief Medical Officer and President of Nxera Pharma Japan
Tokyo, Japan and Cambridge, UK – Nxera Pharma Co., Ltd. – formerly known as Sosei Group or Sosei Heptares – announces the appointment of Dr. Makoto Sugita, M.D., Ph.D., MBA, as President of Nxera Pharma Japan, and Executive Officer, Executive Vice President and Chief Medical Officer (C...